Takehara, et al., "Dipyridamole Decreases Platelet-Derived Growth Factor Levels in Human Serum", Arteriosclerosis, 7, No. 2, 152-158 (1987). |
Landymore, et al., "The Effects of Aspirin and Dipyridamole on Platelet Function and Prevention of Intimal Hyperplasia in Autologous Vein Grafts", The Canadian Journal of Cardiology, 4, No. 4, 56-59 (1988). |
Ingermann-Wojenski, et al., "Model System to Study Interaction of Platelets with Damaged Arterial Wall", Experimental and Molecular Pathology, 48, No. 1, 116-134 (1988). |
Lindblad, et al., "Effect of Anticoagulant and Antiplatelet Drugs on In Vitro Smooth Muscle Proliferation", Artery, 15, No. 4, 225-233 (1988). |
Hagen, et al., "Antiplatelet Therapy Reduces Aortic Intimal Hyperplasia Distal to Small Diameter ascular Prostheses (PTFE) in NonHuman Primates", Annals of Surgery, 195, No. 3, 328-339, (1992). |
Radic et al., "The role of aspirin and dipyramidole on vascular DNA synthesis and intimal hyperplasia following deendothialization", J. Surg. Res., 41(1), 84-91, 1986. (Abstract only). |
Harker, et al., Arteriosclerosis 10: 828a (Sep. 1990). |
Schwartz, et al., The New England Journal of Medicine 318: 1714-1719 (Jun., 1988). |
Hermans, et al., American Heart Journal 122: 171-187 (Jul. 1991). |
Faxon, et al., The American Journal of Cardiology 53: 72c-76c (Jul. 1984). |
Bankhead, Medical World News: 26--34 (Feb. 1991). |
Sanz, et al., Circulation 82: 765-773 (Sep. 1990). |
Beckett, et al., Arthritis and Rheumatism 27: 1137-1143 (Oct. 1984). |